Entrada Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Entrada Therapeutics's balance sheet done over the years? Its assets were worth $469,192,000 last year, which is more than in the previous period. 48% of Entrada Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $226,832,000, which means an increase by 474% compared compared to last year.

Debt to Assets

Entrada Therapeutics, Inc. (NASDAQ:TRDA): Debt to assets
2019 18238000 33.75M 185.09%
2020 43527000 85.01M 195.32%
2021 305833000 7.11M 2.33%
2022 252056000 39.50M 15.67%
2023 469192000 226.83M 48.35%

TRDA Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
67.60M45.15M291.06M39.04M16.84M
Short term investments
284.36M143.55M000
Net receivables
5.87M0000
Inventory
00000
Other current assets
11.92M21.16M7.63M904K593K
Total current assets
369.77M209.87M298.7M39.94M17.43M
Non-current assets:
Property, Plant and Equipment
92.68M33.02M6.26M3.03M801K
Goodwill
00000
Intangible assets
00000
Long term investments
03.95M000
Other non-current assets
6.74M5.21M872K541K-801K
Total non-current assets
99.42M42.18M7.13M3.57M801K
Total assets
469.19M252.05M305.83M43.52M18.23M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
132.26M0000
Short term debt
15.81M8.40M000
Total current liabilities
158.79M21.97M6.71M3.35M1.92M
Non-current liabilities:
Long term debt
60.32M17.53M000
Deferred tax
00000
Other non-current liabilities
000031.83M
Total non-current liabilities
68.03M17.53M396K81.65M31.83M
Total liabilities
226.83M39.50M7.11M85.01M33.75M
Data sourceData sourceData source